Costs versus benefits: best possible and best practical treatment regimens for HIV
DOI10.1007/S00285-006-0059-1zbMATH Open1115.92030OpenAlexW2005646672WikidataQ51925691 ScholiaQ51925691MaRDI QIDQ2373250FDOQ2373250
Authors: Olga Krakovska, Lindi M. Wahl
Publication date: 17 July 2007
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s00285-006-0059-1
Recommendations
- Optimal drug treatment regimens for HIV depend on adherence
- An optimal strategy for HIV multitherapy
- Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting
- Optimal control for HIV treatment
- Optimal multi-therapeutic HIV treatment using a global optimal switching scheme
- Optimal HIV treatment by maximising immune response
- Optimal resource allocation for HIV prevention and control
- Dynamic multidrug therapies for HIV: Optimal and STI control approaches
- Optimal controls of the highly active antiretroviral therapy
- Optimal therapy regimens for treatment-resistent mutations of HIV
Medical applications (general) (92C50) Applications of optimal control and differential games (49N90) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)
Cites Work
- Title not available (Why is that?)
- Optimal control of the chemotherapy of HIV
- Predicting differential responses to structured treatment interruptions during HAART
- Dynamic multidrug therapies for HIV: Optimal and STI control approaches
- HIV dynamics: Modeling, data analysis, and optimal treatment protocols
- Title not available (Why is that?)
- Optimal control of an HIV immunology model
- Optimal HIV treatment by maximising immune response
- A model for treatment strategy in the chemotherapy of AIDS
- Stochastic optimal therapy for enhanced immune response
- Title not available (Why is that?)
Cited In (11)
- Mathematical analysis of an HIV model with impulsive antiretroviral drug doses
- Multiobjective optimal control of HIV dynamics
- Kinetic model of HIV infection including hematopoietic progenitor cells
- The evaluation and prediction model of the effect of AIDS therapy
- Explicitly accounting for antiretroviral drug uptake in theoretical HIV models predicts long-term failure of protease-only therapy
- Treatment monitoring of HIV-infected patients based on mechanistic models
- Optimal drug treatment regimens for HIV depend on adherence
- Optimal control of HIV dynamic using embedding method
- Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting
- A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
- Optimal therapy regimens for treatment-resistent mutations of HIV
This page was built for publication: Costs versus benefits: best possible and best practical treatment regimens for HIV
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2373250)